Novartis Pharmaceuticals UK Limited, Frimley (United Kingdom of Great Britain & Northern Ireland)
Follow
Contributor content
Presentation
Better health-related quality of life in patients treated with sacubitril/valsartan compared with enalapril, irrespective of NYHA class: Analysis of EQ-5D in PARADIGM-HF
